Abstract
The pharmacokinetics of ofloxacin were investigated in eight healthy male volunteers. A single infusion (200 mg over 0.5 h) was performed on day 1, followed by a washout period of 2 weeks. Repeated administrations were performed for 4 days (200 mg every 12 h). Pharmacokinetic parameters were determined from the plasma decay curves of the single and the last of the multiple administrations. Ofloxacin kinetics after the single dose were best described by a two-phase curve with a total body clearance of 241.6 +/- 43.3 ml min-1, a volume of distribution of 112 +/- 23.1 liters, and an elimination half-life of 5.4 +/- 0.8 h. The extrapolated area under the curve (AUC0-infinity) was 14 +/- 2.3 mg.h liter-1. The pharmacokinetics were not significantly modified by repeated administration, demonstrated mainly by the AUC0-12 value of the last infusion (13.4 +/- 2.2 mg.h liter-1). We conclude that, with intravenous multiple doses every 12 h, the steady state is reached within 24 to 36 h and no abnormal accumulation or changes in pharmacokinetic parameters occur.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dagrosa E. E., Verho M., Malerczyk V., de Looze S., Hajdú P., Toyodera K. Multiple-dose pharmacokinetics of ofloxacin, a new broad-spectrum antimicrobial agent. Clin Ther. 1986;8(6):632–645. [PubMed] [Google Scholar]
- Fillastre J. P., Leroy A., Humbert G. Ofloxacin pharmacokinetics in renal failure. Antimicrob Agents Chemother. 1987 Feb;31(2):156–160. doi: 10.1128/aac.31.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kalager T., Digranes A., Bergan T., Rolstad T. Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state. J Antimicrob Chemother. 1986 Jun;17(6):795–800. doi: 10.1093/jac/17.6.795. [DOI] [PubMed] [Google Scholar]
- Lode H., Höffken G., Olschewski P., Sievers B., Kirch A., Borner K., Koeppe P. Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother. 1987 Sep;31(9):1338–1342. doi: 10.1128/aac.31.9.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Monk J. P., Campoli-Richards D. M. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1987 Apr;33(4):346–391. doi: 10.2165/00003495-198733040-00003. [DOI] [PubMed] [Google Scholar]
- Verho M., Malerczyk V., Dagrosa E., Korn A. The effect of food on the pharmacokinetics of ofloxacin. Curr Med Res Opin. 1986;10(3):166–171. doi: 10.1185/03007998609110436. [DOI] [PubMed] [Google Scholar]